This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Kurt Vesterager Gothelf, Ph.D.
Professor, Department of Chemistry and iNANO at Aarhus University
Speaker

Profile

Kurt Vesterager Gothelf graduated from Aarhus University, Denmark in 1995 in organic chemistry, and did post-doctoral studies at Duke University, USA. From 2001 he advanced from assistant professor and associate professor to full professor in 2007 at Aarhus University. From 2007-2017, he was the head of the Center for DNA Nanotechnology funded by the Danish National Research Foundation. He is co-founder of the medtech startup Medicquant. His current research is within the areas of nucleic acid chemistry, bioconjugation, biosensors, and DNA nanotechnology

Agenda Sessions

  • Modification of Oligonucleotides at Phosphorus

    11:10am